Drug Discovery · New Haven, CT · Founded 2018 · Privately Held (backing)
Developer of a drug discovery platform designed to create therapeutic and precision medicines. Halda Therapeutics is based in New Haven, CT and was founded in 2018. Its last known valuation is $3 billion. It has raised $227 million across 3 recorded rounds; the latest was a $126 million Series B in Jul 2024.
Last price · $/share
—
Implied valuation
$3.0B
Total raised
$227.1M
Last round
Later Stage VC (Series B)
Jul 2024
No prints on record
No secondary trades in Halda Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Halda Therapeutics with a free account
·The complete investor list: 14 names
·Watch Halda Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Halda Therapeutics stock.
